+171.5%
CBRE vs BBIO
+136.9%
+34.6%
-53.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | BBIO | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.2% | -4.7% | +3.5% | -0.7% |
| 7D | -7.2% | -3.9% | -3.4% | -6.8% |
| 30D | -6.4% | -13.4% | +7.0% | -5.0% |
| 3M | +2.9% | +7.6% | -4.6% | +1.8% |
| 6M | +2.5% | -2.4% | +5.0% | +2.3% |
| YTD | -14.2% | -5.2% | -9.0% | -14.5% |
| 1Y | -15.1% | +36.9% | -52.0% | -19.2% |
| 3Y | +61.9% | +155.2% | -93.3% | +40.6% |
| 5Y | +42.4% | +44.0% | -1.6% | +12.3% |
| All | +171.5% | +136.9% | +34.6% | +71.7% |
Cumulative growth
Daily Returns
Daily percentage return beside BBIO.
Daily Out/Under-Performance
Portfolio return minus BBIO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded BBIO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling